• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微生物对抗生素的耐药性与有效的抗生素治疗

Microbial Resistance to Antibiotics and Effective Antibiotherapy.

作者信息

Chiș Adriana Aurelia, Rus Luca Liviu, Morgovan Claudiu, Arseniu Anca Maria, Frum Adina, Vonica-Țincu Andreea Loredana, Gligor Felicia Gabriela, Mureșan Maria Lucia, Dobrea Carmen Maximiliana

机构信息

Preclinical Department, Faculty of Medicine, "Lucian Blaga" University of Sibiu, 550169 Sibiu, Romania.

出版信息

Biomedicines. 2022 May 12;10(5):1121. doi: 10.3390/biomedicines10051121.

DOI:10.3390/biomedicines10051121
PMID:35625857
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9138529/
Abstract

Currently, the efficacy of antibiotics is severely affected by the emergence of the antimicrobial resistance phenomenon, leading to increased morbidity and mortality worldwide. Multidrug-resistant pathogens are found not only in hospital settings, but also in the community, and are considered one of the biggest public health concerns. The main mechanisms by which bacteria develop resistance to antibiotics include changes in the drug target, prevention of entering the cell, elimination through efflux pumps or inactivation of drugs. A better understanding and prediction of resistance patterns of a pathogen will lead to a better selection of active antibiotics for the treatment of multidrug-resistant infections.

摘要

目前,抗生素的疗效受到抗菌耐药现象出现的严重影响,导致全球发病率和死亡率上升。多重耐药病原体不仅在医院环境中被发现,在社区中也有发现,被认为是最大的公共卫生问题之一。细菌对抗生素产生耐药性的主要机制包括药物靶点的改变、阻止药物进入细胞、通过外排泵排出药物或使药物失活。更好地理解和预测病原体的耐药模式将有助于更好地选择活性抗生素来治疗多重耐药感染。

相似文献

1
Microbial Resistance to Antibiotics and Effective Antibiotherapy.微生物对抗生素的耐药性与有效的抗生素治疗
Biomedicines. 2022 May 12;10(5):1121. doi: 10.3390/biomedicines10051121.
2
Emergence of a Potent Multidrug Efflux Pump Variant That Enhances Campylobacter Resistance to Multiple Antibiotics.一种增强弯曲杆菌对多种抗生素耐药性的强效多药外排泵变体的出现。
mBio. 2016 Sep 20;7(5):e01543-16. doi: 10.1128/mBio.01543-16.
3
Nano-Strategies to Fight Multidrug Resistant Bacteria-"A Battle of the Titans".对抗多重耐药细菌的纳米策略——“巨头之战”
Front Microbiol. 2018 Jul 2;9:1441. doi: 10.3389/fmicb.2018.01441. eCollection 2018.
4
The ins and outs of RND efflux pumps in Escherichia coli.大肠杆菌中RND外排泵的来龙去脉
Front Microbiol. 2015 Jun 10;6:587. doi: 10.3389/fmicb.2015.00587. eCollection 2015.
5
RND Pump-Mediated Efflux of Amotosalen, a Compound Used in Pathogen Inactivation Technology to Enhance Safety of Blood Transfusion Products, May Compromise Its Gram-Negative Anti-Bacterial Activity.RND 泵介导的氨甲喋呤外排,一种用于病原体灭活技术以提高输血产品安全性的化合物,可能会损害其革兰氏阴性抗菌活性。
mSphere. 2023 Apr 20;8(2):e0067322. doi: 10.1128/msphere.00673-22. Epub 2023 Feb 28.
6
Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance?生物膜的体外和体内研究:单一机制是否意味着交叉耐药?
J Appl Microbiol. 2002;92 Suppl:98S-110S.
7
Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.应对多重耐药菌的威胁及未来问题
Curr Top Microbiol Immunol. 2016;398:3-33. doi: 10.1007/82_2016_492.
8
Tackling multidrug-resistant Staphylococcus aureus by natural products and their analogues acting as NorA efflux pump inhibitors.通过天然产物及其类似物作为NorA外排泵抑制剂来应对耐多药金黄色葡萄球菌。
Bioorg Med Chem. 2023 Feb 15;80:117187. doi: 10.1016/j.bmc.2023.117187. Epub 2023 Jan 27.
9
Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance?生物膜的体外和体内研究:单一机制是否意味着交叉耐药?
Symp Ser Soc Appl Microbiol. 2002(31):98S-110S.
10
Bacterial multidrug efflux pumps: mechanisms, physiology and pharmacological exploitations.细菌多药外排泵:机制、生理学及药理学应用
Biochem Biophys Res Commun. 2014 Oct 17;453(2):254-67. doi: 10.1016/j.bbrc.2014.05.090. Epub 2014 May 27.

引用本文的文献

1
Proteomic Insights into Bacterial Responses to Antibiotics: A Narrative Review.蛋白质组学对细菌抗生素反应的见解:一篇综述
Int J Mol Sci. 2025 Jul 27;26(15):7255. doi: 10.3390/ijms26157255.
2
Antimicrobial resistance of spp. isolated from canine specimens submitted to a veterinary diagnostic laboratory in South Africa.从提交给南非一家兽医诊断实验室的犬类标本中分离出的 spp. 的抗菌药物耐药性。
Vet World. 2025 Jun;18(6):1421-1432. doi: 10.14202/vetworld.2025.1421-1432. Epub 2025 Jun 6.
3
A single-vector CRISPR/Cas9 system for genome editing and heterologous enzyme secretion in Saccharomyces cerevisiae: a case study on pectate lyase for coffee mucilage removal.

本文引用的文献

1
Combating antimicrobial resistance: an evidence-based overview of bacteriophage therapy.对抗抗菌素耐药性:噬菌体疗法的循证概述
Postgrad Med J. 2022 Apr 4. doi: 10.1136/postmj/postgradmedj-2022-141546.
2
Practical Assessment of an Interdisciplinary Bacteriophage Delivery Pipeline for Personalized Therapy of Gram-Negative Bacterial Infections.用于革兰氏阴性菌感染个性化治疗的跨学科噬菌体递送流程的实践评估
Pharmaceuticals (Basel). 2022 Feb 2;15(2):186. doi: 10.3390/ph15020186.
3
Bacterial biofilm infections, their resistance to antibiotics therapy and current treatment strategies.
用于酿酒酵母基因组编辑和异源酶分泌的单载体CRISPR/Cas9系统:以用于去除咖啡黏液的果胶裂解酶为例的研究
Biotechnol Lett. 2025 Jul 19;47(4):78. doi: 10.1007/s10529-025-03621-4.
4
Genomes of 211 Actinomycete Strains from Diverse Environments.来自不同环境的211株放线菌菌株的基因组
Sci Data. 2025 Jul 15;12(1):1225. doi: 10.1038/s41597-025-05567-8.
5
Lights out for Superbugs: Is antimicrobial blue light a potential approach for future infection Control?超级细菌的熄灯时刻:抗菌蓝光是未来感染控制的潜在方法吗?
Adv Drug Deliv Rev. 2025 Sep;224:115654. doi: 10.1016/j.addr.2025.115654. Epub 2025 Jul 10.
6
Rational Antibiotic Use in Office Practice.门诊实践中的合理抗生素使用
Indian J Pediatr. 2025 Jul 2. doi: 10.1007/s12098-025-05631-6.
7
Insights on Zosteric Acid Analogues Activity Against Candida albicans Biofilm Formation.关于带状疱疹酸类似物对白色念珠菌生物膜形成的活性见解。
ACS Omega. 2025 May 20;10(21):22285-22295. doi: 10.1021/acsomega.5c03581. eCollection 2025 Jun 3.
8
Next-Generation Wound Care: A Scoping Review on Probiotic, Prebiotic, Synbiotic, and Postbiotic Cutaneous Formulations.下一代伤口护理:关于益生菌、益生元、合生元和后生元皮肤制剂的范围综述。
Pharmaceuticals (Basel). 2025 May 9;18(5):704. doi: 10.3390/ph18050704.
9
Advancements in AI-driven drug sensitivity testing research.人工智能驱动的药物敏感性测试研究进展。
Front Cell Infect Microbiol. 2025 May 2;15:1560569. doi: 10.3389/fcimb.2025.1560569. eCollection 2025.
10
Methylglyoxal Alone or Combined with Light-Emitting Diodes/Complex Electromagnetic Fields Represent an Effective Response to Microbial Chronic Wound Infections.甲基乙二醛单独或与发光二极管/复合电磁场联合使用是对微生物慢性伤口感染的有效应对方法。
Antibiotics (Basel). 2025 Apr 10;14(4):396. doi: 10.3390/antibiotics14040396.
细菌生物膜感染及其对抗生素治疗的耐药性和当前的治疗策略。
Biomed Mater. 2022 Feb 14;17(2). doi: 10.1088/1748-605X/ac50f6.
4
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.2019 年全球细菌对抗菌药物耐药性的负担:系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
5
β-lactam Resistance in : Current Status, Future Prospects.β-内酰胺类抗生素耐药性:现状与未来展望
Pathogens. 2021 Dec 18;10(12):1638. doi: 10.3390/pathogens10121638.
6
Overcoming the rising incidence and evolving mechanisms of antibiotic resistance by novel drug delivery approaches - An overview.通过新型药物递送方法克服抗生素耐药性不断上升的发生率和不断演变的机制——综述
Adv Drug Deliv Rev. 2022 Feb;181:114078. doi: 10.1016/j.addr.2021.114078. Epub 2021 Dec 9.
7
Dendrimers as Non-Viral Vectors in Gene-Directed Enzyme Prodrug Therapy.树状高分子作为基因定向酶前药治疗中的非病毒载体。
Molecules. 2021 Oct 1;26(19):5976. doi: 10.3390/molecules26195976.
8
Manufacturing Bacteriophages (Part 2 of 2): Formulation, Analytics and Quality Control Considerations.噬菌体的生产(第二部分):制剂、分析及质量控制考量
Pharmaceuticals (Basel). 2021 Sep 2;14(9):895. doi: 10.3390/ph14090895.
9
The Particularities of Pharmaceutical Care in Improving Public Health Service during the COVID-19 Pandemic.新冠疫情期间改善公共卫生服务的药学服务的特殊性。
Int J Environ Res Public Health. 2021 Sep 16;18(18):9776. doi: 10.3390/ijerph18189776.
10
Antimicrobial Peptides: A Potent Alternative to Antibiotics.抗菌肽:抗生素的有力替代品。
Antibiotics (Basel). 2021 Sep 10;10(9):1095. doi: 10.3390/antibiotics10091095.